Chiron Warns It Will Produce Fewer Flu Vaccines, Slashes Earnings Estimates PAUL ELIAS AP Biotechnology Writer
The Associated Press
Published: Jun 15, 2005
http://ap.tbo.com/ap/breaking/MGBLX7B50AE.html SAN FRANCISCO(AP) - Chiron Corp. said Wednesday it may not deliver as many flu shots this year as it had promised, prompting the beleaguered biotechnology company to cut its 2005 financial forecast.
The Emeryville, Calif.-based company, one of only two major makers of the nation's flu vaccine, caused a public health scare in October when it failed to deliver 50 million shots at the beginning of flu season because of manufacturing problems. That was about half the nation's expected vaccine supply.
Chiron said its Liverpool, England, factory is still plagued with problems and that it now plans to produce 18 million to 26 million doses of its Fluvirin vaccine for the 2005-2006 season, down from a previous forecast of 25 million to 30 million doses.
Since the company's high-profile failure was announced in October, its stock has fallen more than 20 percent. Meanwhile, other drug makers are attempting to enter a U.S. flu vaccine market that was previously locked up by Chiron and the French pharmaceutical Sanofi-Aventis SA.